SCHEMBL8780866

SCHEMBL8780866

CCCCCC(N)c1ccc(OCc2ccccn2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.59
PARP10 Q53GL7 1/20 0.48
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
KDM4E B2RXH2 1/20 0.47
LPAR3 Q9UBY5 3/20 0.46
ENPP2 Q13822 1/20 0.45
GRIN2D O15399 1/20 0.44
GRIN3B O60391 1/20 0.44
GRIN1 Q05586 1/20 0.44
GRIN2A Q12879 1/20 0.44
GRIN2B Q13224 1/20 0.44
GRIN2C Q14957 1/20 0.44
GRIN3A Q8TCU5 1/20 0.44
CYP1A2 P05177 3/20 0.42
CYP2C9 P11712 3/20 0.42
CYP2D6 P10635 2/20 0.42
CYP3A4 P08684 2/20 0.42
HPGD P15428 2/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8781051 0.86 GPBAR1 (0.53) SLC2A1PARP10ALDH1A1SMN1; SMN2GRIN2D
SCHEMBL10636234 0.86 MAPK1 (0.51) PARP10ALDH1A1SMN1; SMN2KDM4ELPAR3
SCHEMBL8781040 0.82 SYK (0.45) SLC2A1ALDH1A1SYKAURKBINCENP
SCHEMBL8781013 0.82 PDE4D (0.45) SLC2A1SMN1; SMN2CYP1A2CYP2D6CYP3A4
SCHEMBL8781026 0.80 CYP1A2 (0.47) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8780987 0.79 CYP1A2 (0.47) SLC2A1LPAR3CYP1A2TLR8TLR7
Hydrochloric Acid SCHEMBL22159185 0.78 PARP10 (0.55) PARP10ALDH1A1SMN1; SMN2KDM4EGRIN2D
SCHEMBL8780979 0.78 SYK (0.54) CYP1A2TLR8TLR7KMT2ASYK
SCHEMBL28552486 0.77 PARP10 (0.51) PARP10ALDH1A1SMN1; SMN2KDM4ELPAR3
SCHEMBL9018955 0.77 CYSLTR1 (0.61) ALDH1A1SMN1; SMN2CYP1A2CYP2C9CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0773218-A1 N-(Piperazinylalkoxyphenyl)-N'phenylalkylurea derivatives as ACAT inhibitors for the treatment of atheroschlerosis MITSUBISHI CHEMICAL CORPORATION (JP) 1997-05-14 EP disclosed